US stocks edge higher as banks help offset healthcare slide

→ Trump’s last act as President (From Porter & Company) (Ad)

The New York Stock Exchange is seen in New York, Monday, Nov. 23, 2020. Stocks were mostly lower in early trading Thursday, May 6, 2021. Healthcare stocks were among the biggest decliners after news last night that the White House supports waiving intellectual property rights for coronavirus vaccines to help immunize poorer countries faster. (AP Photo/Seth Wenig, File)

Banks and household goods makers helped lift stocks on Wall Street mostly higher in afternoon trading Thursday, though the gains were muted by a pullback in health care and other sectors.

The S&P 500 was up 0.1% as of 2:38 p.m. Eastern after recovering from an early slide. The benchmark index is on track for a small weekly loss following a choppy week of trading. Treasury yields were mostly lower. Oil prices fell.

Investors are still digesting the latest corporate earnings and turning their attention to job growth as the the U.S. pushes on with its economic recovery. Job growth has been one of the keys to a sustained economic rebound, but it has been lagging behind other areas of the economy such as retail sales and consumer confidence.

“Continued job gains through the year are going to be important to continue to move things ahead,” said James Ragan, director of wealth management research at D.A. Davidson.

The Dow Jones Industrial Average was up 113 points, or 0.3%, to 34,341, while the Nasdaq Composite was down 0.6%. Smaller company stocks also lost ground, knocking the Russell 2000 index 1.1% lower.

Healthcare stocks fell broadly after news late Wednesday that the White House supports waiving intellectual property rights for coronavirus vaccines to help immunize poorer countries faster. That slide was countered by gains in household goods makers, banks and communication companies.

Shares of drugmaker Moderna lost 1.9% after the company reported its first-ever quarterly profit, helped by the company's coronavirus vaccine. The drop was largely tied to the news from the White House, as shares of other drug companies fell. Pfizer slid 1.5% and Merck slipped 0.3%.

Shares of Johnson & Johnson were relatively unchanged by the news, partly because J&J has other businesses like Band-Aids, the pain reliever Tylenol and its baby products franchise. The stock inched up 0.1%


Investors remain focused on corporate earnings, with results from Wall Street Journal publisher News Corp after the closing bell, and results from Cigna, Equifax and insurance giant AIG on Friday. Of the S&P 500 companies reporting so far, 84% topped analysts’ expectations, according to FactSet.

Investors’ attention is turning to Friday’s jobs report for April. Economists expect the data to show employers hired 975,000 workers last month as the economy accelerated out of the pandemic and vaccines rolled out nationwide. The unemployment rate is expected to drop to 5.8% from 6%.

There have already been signs that the labor market is improving. The Labor Department said Thursday that the number of Americans who filed for unemployment benefits last week fell to a pandemic low of 498,000. The payroll processing company ADP said Wednesday that private employers hired 742,000 workers last month.

→ Biden replacement revealed? (From Paradigm Press) (Ad)

Should you invest $1,000 in American International Group right now?

Before you consider American International Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American International Group wasn't on the list.

While American International Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Johnson & Johnson (JNJ)
4.9271 of 5 stars
$151.16+4.5%3.15%9.42Hold$175.86
Pfizer (PFE)
4.977 of 5 stars
$27.17+6.0%6.18%75.47Hold$36.33
News (NWSA)
3.0947 of 5 stars
$23.84+0.2%0.84%59.60Buy$29.50
The Cigna Group (CI)
4.87 of 5 stars
$357.08+0.0%1.57%20.53Moderate Buy$362.14
American International Group (AIG)
4.7657 of 5 stars
$75.83+0.7%1.90%15.20Moderate Buy$80.38
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

JNJ shares hit a low, trading near $145 at under 14X earnings. With a high dividend yield, it's poised for a rebound.

Search Headlines: